Behav Pharmacol 6 : 562567
It gives us pause to say for an average employer group out there if youre investing in this medication for your employees, dont expect to see a return in year one. According to Joseph Leach, M.D., Senior Vice President and Chief Medical Officer at Prime, We will need results of ongoing, multi-year studies to see if this treatment has downstream impacts on other health conditions, including cardiovascular events and diabetes development prevention, which are key benefits to weight loss management
Since GLP-1s have such an impact on the metabolic processes in the body, stopping them also causes significant changes in your body
The Bigger Issue Isnt the Drug Its Your Appetite Although tirzepatide does not appear to significantly enter breast milk, it does significantly reduce appetite
Men presenting with UTI symptoms warrant careful evaluation, as UTIs in men are generally considered complicated infections and may indicate underlying urological abnormalities such as prostatic hypertrophy or urinary retention requiring further investigation